|
1
|
Lactase AS: Post-transplant
lymphoproliferative disorders. Oncologist. 11:674–680. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Choi JH, Park BB, Suh C, Won JH, Lee WS
and Shin HJ: Clinical characteristics of monomorphic
post-transplant lymphoproliferative disorders. J Korean Med Sci.
25:523–526. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Savoie A, Perpête C, Carpentier L, Joncas
J and Alfieri C: Direct correlation between the load of
Epstein-Barr virus-infected lymphocytes in the peripheral blood of
pediatric transplant patients and risk of lymphoproliferative
disease. Blood. 83:2715–2722. 1994.PubMed/NCBI
|
|
4
|
Chang MS and Kim WH: Epstein-Barr virus in
human malignancy: A special reference to Epstein-Barr virus
associated gastric carcinoma. Cancer Res Treat. 37:257–267. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Leblond V, Davi F, Charlotte F, Dorent R,
Bitker MO, Sutton L, Gandjbakhch I, Binet JL and Raphael M:
Post-transplant lymphoproliferative disorders not associated with
Epstein-Barr virus: A distinct entity? J Clin Oncol. 16:2052–2059.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nelson BP, Nalesnik MA, Bahler DW, Locker
J, Fung JJ and Swerdlow SH: Epstein-Barr virus-negative
post-transplant lymphoproliferative disorders: A distinct entity?
Am J Surg Pathol. 24:375–385. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gottschalk S, Rooney CM and Heslop HE:
Post-transplant lymphoproliferative disorders. Annu Rev Med.
56:29–44. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Loren AW, Porter DL, Stadtmauer EA and
Tsai DE: Post-transplant lymphoproliferative disorder: A review.
Bone Marrow Transplant. 31:145–155. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Frizzera G, Hanto DW, Gajl-Peczalska KJ,
Rosai J, McKenna RW, Sibley RK, Holahan KP and Lindquist LL:
Polymorphic diffuse B-cell hyperplasias and lymphomas in renal
transplant recipients. Cancer Res. 41:4262–4279. 1981.PubMed/NCBI
|
|
10
|
Hanto DW, Frizzera G, Purtillo DT,
Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL and
Najarian JS: Clinical spectrum of lymphoproliferative disorders in
renal transplant recipients and evidence for the role of
Epstein-Barr virus. Cancer Res. 41:4253–4261. 1981.PubMed/NCBI
|
|
11
|
Locker J and Nalesnik M: Molecular genetic
analysis of lymphoid tumors arising after organ transplantation. Am
J Pathol. 135:977–987. 1989.PubMed/NCBI
|
|
12
|
Randhawa PS, Jaffe R, Demetris AJ,
Nalesnik M, Starzl TE, Chen YY and Weiss LM: Expression of
Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver
specimens from transplant recipients with post-transplantation
lymphoproliferative disease. N Engl J Med. 327:1710–1714. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Knowles DM, Cesarman E, Chadburn A,
Frizzera G, Chen J, Rose EA and Michler RE: Correlative morphologic
and molecular genetic analysis demonstrates three distinct
categories of post-transplantation lymphoproliferative disorders.
Blood. 85:552–565. 1995.PubMed/NCBI
|
|
14
|
Capello D and Gaidano G: Post-transplant
lymphoproliferative disorders: Role of viral infection, genetic
lesions and antigen stimulation in the pathogenesis of the disease.
Mediterr J Hematol Infect Dis. 1:e20090182009.PubMed/NCBI
|
|
15
|
Mañez R, Breinig MC, Linden P, Wilson J,
Torre-Cisneros J, Kusne S, Dummer S and Ho M: Posttransplant
lymphoproliferative disease in primary Epstein-Barr virus infection
after liver transplantation: The role of cytomegalovirus disease. J
Infect Dis. 176:1462–1467. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jox A, Rohen C, Belge G, Bartnitzke S,
Pawlita M, Diehl V, Bullerdiek J and Wolf J: Integration of
Epstein-Barr virus in Burkitt's lymphoma cells leads to a region of
enhanced chromosome instability. Ann Oncol. 8 Suppl 2:S131–S135.
1997. View Article : Google Scholar
|
|
17
|
Morscio J, Dierickx D, Ferreiro JF,
Herreman A, Van Loo P, Bittoun E, Verhoef G, Matthys P, Cools J,
Wlodarska I, et al: Gene expression profiling reveals clear
differences between EBV-positive and EBV-negative posttransplant
lymphoproliferative disorders. Am J Transplant. 13:1305–1316. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Evens AM, David KA, Helenowski I, Nelson
B, Kaufman D, Kircher SM, Gimelfarb A, Hattersley E, Mauro LA,
Jovanovic B, et al: Multicenter analysis of 80 solid organ
transplantation recipients with post-transplantation
lymphoproliferative disease: Outcomes and prognostic factors in the
modern era. J Clin Oncol. 28:1038–1046. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brunstein CG, Hirsch BA, Hammerschmidt D,
McGlennen RC, Nguyen PL and Verfaillie CM: Leukemia in donor cells
after allogeneic hematopoietic stem cell transplant. Bone Marrow
Transplant. 29:999–1003. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kauffman Myron H, McBride MA, Cherikh WS,
Spain PC, Marks WH and Roza AM: Transplant tumor registry: Donor
related malignancies. Transplantation. 74:358–362. 2002. View Article : Google Scholar : PubMed/NCBI
|
